Radiographic, MR or ultrasound contrast media in pregnant or breast-feeding women: What are the key issues?;Röntgen-, MR- oder Ultraschallkontrastmittel während der Schwangerschaft oder Stillzeit: Was ist zu beachten?

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 185, Issue 1, 2013, Pages 13-25

  Frohlich J M ^a   Kubik Huch, R A ^b  

^a Guerbet AG   (Switzerland)

^b Cantonal Hospital Baden   (Switzerland)

Author keywords

contrast agents; fetus; genital reproductive

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; IODINATED CONTRAST MEDIUM; MACROCYCLIC COMPOUND; SULFUR HEXAFLUORIDE;

ARTICLE; BREAST FEEDING; CONTRAST ENHANCEMENT; DRUG STABILITY; EMBRYOTOXICITY; ENVIRONMENTAL EXPOSURE; HUMAN; LACTATION; LOW DRUG DOSE; NEWBORN ASSESSMENT; NUCLEAR MAGNETIC RESONANCE; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RADIOGRAPHY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TERATOGENICITY; THYROID FUNCTION; ULTRASOUND;

CONTRAST MEDIA; DIAGNOSTIC IMAGING; FEMALE; HUMANS; LACTATION; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84871718100     PISSN: 14389029     EISSN: 14389010     Source Type: Journal    
DOI: 10.1055/s-0032-1325396     Document Type: Article

References (102)

1. Schaefer C., Spielmann H., Vetter K. Arzneiverordnung in Schwangerschaft und Stillzeit. 7. Aufl Münschen Urban & Fischer Verlag: 2006
2. Van der Molen A. J., Thomsen H. S., Morcos S. K. et al. Effect of iodinated contrast media on thyroid function in adults. Eur Radiol: 2004; 14 902 907 (Pubitemid 38678914)
3. Bourin M., Jolliet P., Ballereau F. An overview of the clinical pharmacokinetics of x-ray contrast media. Clin Pharmacokinet: 1997; 32 180 193 (Pubitemid 27122519)
4. ESUR (European Society of Urogenital Radiology) Kontrastmittel- Leitlinien. - siehe www.esur.org (Version 7.0, Stand August, 2008).
5. ACR Manual on Contrast Media. (Version 7; Stand 2010) http://www.acr.org/SecondaryMainMenuCategories/quality-safety/contrast-manual. aspx
6. Sherry A. D., Caravan P., Lenkinski R. E. Primer on gadolinium chemistry. JMRI: 2009; 30 1240 1248
7. Heinrich M., Uder M. Nephrogenic systemic fibrosis after application of gadolinium-based contrast agents - a status paper. Fortschr Röntgenstr: 2007; 179 613 617 (Pubitemid 47091685)
8. Girardi M., Kay J., Elston D. M. et al. Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations. J Am Acad Dermatol: 2011; 65 1095 1106
9. Bongartz G., Weishaupt D., Mayr M. Neue Kontrastmittelproblematik bei Niereninsuffiziez: Gadolinium-induzierte Nephrogene Systemische Fibrose (NSF). Schweiz Med Forum: 2008; 8 116 123
10. Treinen K. A., Gray T. J., Blazak W. F. Developmental toxicity of mangafodipir trisodium and manganese chloride in Sprague-Dawley rats. Teratology: 1995; 52 109 115
11. Bourrinet P., Bengele H. H., Bonnemain B. et al. Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Invest Radiol: 2006; 41 313 324 (Pubitemid 44406193)
12. Han B. H., Lee K. S., Han J. Y. et al. Pregnancy outcome after 1st-trimester inadvertent exposure to barium sulphate as a contrast media for upper gastrointestinal tract radiography. J Obstet Gynaecol: 2011; 31 586 588
13. Born M., Axmann C., Kader R. et al. Renale Diatrizoatexkretion (Gastrografin) als diagnostisch verwertbarer Hinweis auf ö sophagogastrointestinale Nahtdehiszenzen und Perforationen? Fortschr Röntgenstr: 2004; 176 1617 1623 (Pubitemid 39486493)
14. Webb J. AW. Pregnancy and Lactation. Out of: Contrast media. Safety Issues and ESUR guidelines. 2nd revised edition Berlin Springer: 2008
15. Webb J. AW, Thomsen H. S., Morcos S. K. The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol: 2005; 15 1234 1240 (Pubitemid 40778748)
16. Okuda Y., Sagami F., Tirone P. et al. Reproductive and developmental toxicity study of gadobenate dimeglumine formulation (E7155)(3)-study of embryo-fetal toxicity in rabbits by intravenous administration. The Journal of Toxicological Sciences: 1999; 24 79 87 (Pubitemid 30002832)
17. Rofsky N. M., Pizzarello D. J., Duhaney M. O. et al. Effect of magnetic resonance exposure combined with gadopentetate dimeglumine on chromosomes in animal specimens. Acad Radiol: 1995; 2 492 496
18. Rofsky N. M., Pizzarello D. J., Weinreb J. C. et al. Effect on fetal mouse development of exposure to MR imaging and gadopentetate dimeglumine. JMRI: 1994; 4 805 807
19. Soltys R. A. Summary of preclinical safety evaluation of gadoteridol injection. Invest Radiol: 1992; 27 S7 S11
20. Morisetti A., Bussi S., Tirone P. et al. Toxicological safety evaluation of gadobenate dimeglumine 0.5M solution for injection (Multihance), a new magnetic resonance imaging contrast medium. J Comput Assist Tomogr: 1999; 23 S207 S217 (Pubitemid 30027609)
21. Wible J. H. Jr, Troup C. M., Hynes M. R. et al. Toxicological assessment of gadoversetamide injection (Optimark), a new contrast-enhancement agent for use in magnetic resonance imaging. Invest Radiol: 2001; 36 401 412 (Pubitemid 32656262)
22. Cochran S. T., Norman A. Induction of micronuclei in lymphocytes of patients undergoing excretory urography with ioversol. Invest Radiol: 1994; 29 210 212 (Pubitemid 24099851)
23. Norman A., Cochran S. T., Sayre J. W. Meta-analysis of increases in micronuclei in peripheral blood lymphocytes after angiography or excretory urography. Radiat Res: 2001; 15 740 743 (Pubitemid 32410942)
24. Felder E. Iopamidol toxicology. Invest Radiol: 1984; 19 S168 S170 (Pubitemid 14012781)
25. Shaw D. D., Potts D. G. Toxicology of iohexol. Invest Radiol: 1985; 20 S10 S13
26. Ralston W. H., Robbins M. S., James P. Reproductive, developmental and genetic toxicity of ioversol. Invest Radiol: 1989; 24 S16 S22 (Pubitemid 19161569)
27. Morisetti A., Tirone P., Luzzani F. et al. Toxicological safety assessment of iomeprol, a new x-ray contrast agent. Eur J Radiol: 1994; 18 S21 S31 (Pubitemid 24140174)
28. Heglund I. F., Michelet A. A., Blazak W. F. et al. Preclinical pharmacokinetics and general toxicity of iodixanol. Acta Radiol: 1995; 36 69 82
29. Donandieu A. M., Idee J. M., Doucet D. et al. Toxicological profile of iobitridol, a new nonionic low osmolality contrast medium. Acta Radiol: 1996; 37 17 24 (Pubitemid 126549687)
30. Huch R. Kapitel 17: Plazenta. In: Siegenthaler W. (Hrsg) Klinische Pathophysiologie. 8. Aufl Stuttgart, New York Thieme: 2001; 420 429
31. Fröhlich J. M., Kubik-Huch R. A. Kontrastmittel während der Schwangerschaft und Stillzeit. Kapitel 27. In: Alkadhi H., Leschka S., Stolzmann P. et al. (Eds) Wie funktioniert CT?" Berlin, Heidelberg, New York Springer: 2011
32. Marcos H. B., Semelka R. C., Worowattanakul S. Normal placenta: gadolinium-enhanced dynamic MR imaging. Radiology: 1997; 205 493 496 (Pubitemid 27467331)
33. Kelleher J., Feczko P. J., Radkowski M. A. et al. Neonatal intestinal opacification secondary to transplacental passage of urographic contrast medium. Am J Roentgenol: 1979; 132 63 65 (Pubitemid 9100282)
34. Fitzpatrick J., Speakman J., Kapfer S. A. et al. Transplacental passage of the non-ionic contrast agent iopamidol in twins. Pediatr Radiol: 2011; 41 534 536
35. Hill B. J., Saigal G., Patel S. et al. Transplacental passage of non-ionic contrast agents resulting in fetal bowel opacification: a mimic of pneumopertitoneum in the newborn. Pediatr Radiol: 2007; 37 396 398 (Pubitemid 46390158)
36. Moon A. J., Katzberg R. W., Sherman M. P. Transplacental passage of iohexol. J Pediatr: 2000; 136 548 549 (Pubitemid 30469601)
37. Bourrinet P., Dencausse A., Havard P. et al. Transplacental passage and milk excretion of iobitridol. Invest Radiol: 1995; 30 156 158
38. Dean P. B. Fetal uptake of an intravascular radiologic contrast medium. Fortschr Röntgenstr: 1977; 127 267 270 (Pubitemid 8174775)
39. Vanhaesebrouck P., Verstraete A. G., De Praeter C. et al. Transplacental passage of a nonionic contrast agent. Eur J Pediatr: 2005; 164 408 410 (Pubitemid 40933203)
40. Vagenakis A. G., Braverman L. E. Adverse effects of iodides on thyroid function. Med Clin North Am: 1975; 59 1075 1088
41. Vicens-Calvet E., Potau N., Carreras E. et al. Diagnosis and treatment in utero of goiter with hypothyroidism caused by iodide overload. J Pediatr: 1998; 133 147 148 (Pubitemid 28323925)
42. Panigel M., Wolf G., Zeleznick A. Magnetic resonance imaging of the placenta in rhesus monkeys. Macaca mulatta. J Med Primatol: 1988; 17 3 18 (Pubitemid 18071467)
43. Novak Z., Thurmond A. S., Ross P. L. et al. Gadolinium-DTPA transplacental transfer and distribution in fetal tissue in rabbits. Invest Radiol: 1993; 28 828 830 (Pubitemid 24079734)
44. Okazaki O., Murayama N., Masubucki N. et al. Placental transfer and milk secretion of gadodiamide injection in rats. Arzneimittelfors Drug Res: 1996; 46 83 86 (Pubitemid 26051484)
45. Taillieu F., Salomon L. J., Siauve N. et al. Placental perfusion and permeability: simultaneous assessment with dual-echo contrast-enhanced MR imaging in mice. Radiology: 2006; 241 737 745 (Pubitemid 46190539)
46. Sundgren P. C., Leander P. Is administration of gadolinium-based contrast media to pregnant women and small children justified? JMRI: 2011; 34 750 757
47. Mühler M. R., Clément O., Salomon L. J. et al. Maternofetal pharmacokinetics of a gadolinium chelate contrast agent in mice. Radiology: 2011; 258 455 460
48. Parravicini E., Fontana C., Paterlini G. L. et al. Iodine, thyroid function, and very low birth weight infants. Pediatrics: 1996; 98 730 734
49. Ahmet A., Lawson M. L., Babyn P. et al. Hypothyroidism in neonates post-iodinated contrast media: a systematic review. Acta Paediatrica: 2009; 98 1568 1574
50. Rendl J., Saller B. Schilddrüse und Röntgenkontrastmittel. Dt Arzneiblatt: 2001; 98 A402 A406
51. Etling N., Gehin-Fouque F., Vielh J. P. et al. The iodine content of amniotic fluid and placental transfer of iodinated drugs. Obstet Gynecol: 1979; 53 376 380 (Pubitemid 9110966)
52. Rhee C. M., Bhan I., Alexander E. K. et al. Less is more: association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism. Arch Intern Med 2012: 2012; 172 153 159
53. Stubbe P., Heidermann P., Schumbraad P. et al. Transient congenital hypothyroidism after amniofetography. Eur J Pediatr: 1980; 135 97 99 (Pubitemid 11216976)
54. Atwell T. D., Lteif A. N., Brown D. L. et al. Neonatal thyroid function after administration of IV iodinated contrast agent to 21 pregnant patients. Am J Roentgenol: 2008; 191 268 271 (Pubitemid 351955203)
55. Rajaram S., Exley C. E., Fairlie F. et al. Effect of antenatal iodinated contrast agent on neonatal thyroid function. British J Radiol: 2012; 85 e238 e242
56. Bourjeily G., Chalhoub M., Phornphutkul C. et al. Neonatal thyroid function: effect of a single exposure to iodinated contrast medium in utero. Radiology: 2010; 256 744 750
57. Kochi M. H., Kaloudis E. V., Ahmed W. et al. Effect of in utero exposure of iodinated intravenous contrast on neonatal thyroid function. JCAT: 2012; 36 165 169
58. Morrison J. C., Boyd M., Friedman B. I. et al. The effects of Renografin-60 on the fetal thyroid. Obstet Gynecol: 1973; 42 99 103
59. Thomas C. R., Lang E. K., Lloyd F. P. Fetal pyelography-a method for detecting fetal life. Obstet Gyencol: 1963; 22 335 340
60. Ridge C. A., McDermott S., Freyne B. J. et al. Pulmonary embolism in pregnancy: comparison of pulmonary CT angiography and lung scintigraphy. Am J Roentgenol: 2009; 193 1223 1227
61. Lazarus E., Mayo-Smith W. W., Mainiero M. B. et al. CT in the evaluation of nontraumatic abdominal pain in pregnant women. Radiology: 2007; 244 784 790 (Pubitemid 47292089)
62. Callahan M. J., Poznauskis L., Zurakowski D. et al. Nonionic iodinated intravenous contrast material-related reactions: incidence in large urban childrens hospital-retrospective analysis of data in 12949 patients. Radiology: 2009; 250 674 681
63. Dillman J. R., Strouse P. J., Ellis J. H. et al. Incidence and severity of acute allergic-like reactions to i.v. nonionic iodinated contrast material in children. Am J Roentgenol: 2007; 188 1643 1647 (Pubitemid 46866870)
64. Hauth E., Umutlu L., Forsting M. Contrast-enhanced MR-mammography in a pregnant woman with breast carcinoma. Fortschr Röntgenstr: 2007; 179 1083 1084 (Pubitemid 47596626)
65. Tanaka Y. O., Sohda S., Shigemitsu S. et al. High temporal resolution dynamic contrast MRI in a high risk group for placenta accreta. Magn Reson Imaging: 2001; 19 635 642 (Pubitemid 32751595)
66. De Santis M., Straface G., Cavaliere A. F. et al. Gadolinium periconceptional exposure: pregnancy and neonatal outcome. Acta Obstet Gynecol Scand: 2007; 86 99 101 (Pubitemid 46009534)
67. Schoenut J. P., Semelka R. C., Silverman R. et al. MRI in the diagnosis of Crohns disease in two pregnant women. J Clin Gastroenterol: 1993; 17 244 247 (Pubitemid 23304506)
68. Barkhof F., Heijboer R. J., Algra P. R. Inadvertent i.v. administration of gadopentetate dimeglumine during early pregnancy. Am J Roentgenol: 1992; 158 1171
69. Leyendecker J. R., Gorengaut V., Brown J. J. MR imaging of maternal diseases of the abdomen and pelvis during pregnancy and the immediate postpartum period. RadioGraphics: 2004; 24 1301 1306
70. Birchard K. R., Brown M. A., Hyslop W. B. et al. MRI of acute abdominal and pelvic pain in pregnant patients. Am J Roentgenol: 2005; 184 452 458 (Pubitemid 46657250)
71. Spencer J. A., Tomlinson A. J., Weston M. J. et al. Early report: comparison of breath-hold MR excretory urography, Doppler ultrasound and isotope renography in evaluation of symptomatic hydronephrosis in pregnancy. Clin Radiol: 2000; 55 446 453 (Pubitemid 32054551)
72. Ordén M. R., Gudmundsson S., Helin H. L. et al. Intravascular contrast agent in the ultrasonography of ectopic pregnancy. Ultrasound Obstet Gynecol: 1999; 14 348 352 (Pubitemid 30032359)
73. Ordén M. R., Gudmundsson S., Kirkinen P. Intravascular ultrasound contrast agent: an aid in imaging intervillous blood flow? Placenta: 1999; 20 235 240 (Pubitemid 29121821)
74. Ordén M. R., Leinonen M., Kirkinen P. Contrast-enhanced ultrasonography of uteroplacental circulation does not evoke harmful CTG changes or perinatal events. Fetal Diagn Ther: 2000; 15 139 145 (Pubitemid 30232639)
75. Chou M. M., Tseng J. J., Yi Y. C. et al. Diagnosis of an interstitial pregnancy with 4-dimensional volume contrast imaging. Am J Obstet Gynecol: 2005; 193 1551 1553 (Pubitemid 41395132)
76. Barnett S. B. Routine ultrasound scanning in first trimester: what are the risks? Semin Ultrasound CT MR: 2002; 23 387 391 (Pubitemid 35477569)
77. Rofsky N. M., Weinreb J. C., Litt A. W. Quantitative analysis of gadopentetate dimeglumine excreted in breast milk. JMRI: 1993; 3 131 132
78. Kubik-Huch R. A., Gottstein Alama N. M., Frenzel T. et al. Gadopentetate dimeglumine excretion into human breast milk during lactation. Radiology: 2000; 216 555 558 (Pubitemid 30599881)
79. Schmiedl U., Maravilla K. R., Gerlach R. et al. Excretion of gadopentetate dimeglumine in human breast milk. Am J Roentgenol: 1990; 154 1305 1306 (Pubitemid 20179484)
80. Newman J. Breastfeeding and radiologic procedures. Can Fam Physician: 2007; 53 630 631 (Pubitemid 46650994)
81. Port M., Idée J. M., Medina C. et al. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review. Biometals: 2008; 21 469 490
82. Ilett K. F., Hackett L. P., Paterson J. W. et al. Excretion of metrizamide in milk. Br J Radiol: 1981; 54 537 538 (Pubitemid 11122981)
83. Nielsen S. T., Matheson I., Rasmussen J. N. et al. Excretion of iohexol and metrizoate in human breast milk. Acta Radiol: 1987; 28 523 526 (Pubitemid 18004825)
84. Edmond S., Brunelle F. Gd-DOTA administration at MRI in children younger than 18months of age: immediate adverse reactions. Pediatr Radiol: 2011; 41 1401 1406
85. Simon S. L., Luckyanov N., Bouville A. et al. Transfer of 131-I into human breast milk and transfer coefficients for radiological dose assessments. Health Phys: 2002; 82 796 806 (Pubitemid 34547383)
86. Patel S. J., Reede D. L., Katz D. S. et al. Imaging the pregnant patient for nonobstetric conditions: algorithms and radiation dose considerations. Radiographics: 2007; 27 1705 1722
87. Siegmann K. C., Heuschmid M., Claussen C. D. Diagnostic imaging during pregnancy. Dtsch Med Wochenschrift: 2009; 134 686 689
88. Chen M. M., Coakley F. V., Kaimal A. et al. Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet Gynecol: 2008; 112 333 340
89. Brent R. L. Saving lives and changing family histories: appropriate counseling of pregnant women and men and women of reproductive age, concerning the risk of diagnostic radiation exposure during and before pregnancy. Am J Obstet Gynecol: 2009; 200 4 24
90. Wang P. I., Chong S. T., Kielar A. Z. et al. Imaging of pregnant and lactating patients: part 1, evidence-based review and recommendations. Am J Roentgenol: 2012; 198 778 784
91. Wang P. I., Chong S. T., Kielar A. Z. et al. Imaging of pregnant and lactating patients: part 2, evidence-based review and recommendations. Am J Roentgenol: 2012; 198 785 792
92. van Dijk Azn R., Wetzels J. F., ten Dam M. A. et al. Guideline Precautionary measures for contrast media containing iodine. Ned Tijdschr Geneeskd: 2008; 152 742 746 (Pubitemid 351488222)
93. Weisser G., Steil V., Neff K. W. et al. Radiologie und Schwangerschaft: Grundlagen, Rahmenbedingungen und Belastungen. Der Radiologe: 2012; 52 81 92
94. Spalluto L. B., Woodfield C. A., DeBenedectis C. M. et al. MR Imaging evaluation of abdominal pain during pregnancy: appendicitis and other nonobstetric causes. Radiographics: 2012; 32 317 334
95. Toritsuka N., Daimon H., Sawada S. et al. Mutagenicity study of gadobenate dimeglumine formulation (E7155). J Toxicol Sci: 1999; 24 89 94, 95-101
96. Parvez Z., Kormano M., Satokari K. et al. Induction of mitotic micronuclei by X-ray contast media in human peripheral lymphocytes. Mutation Research/Genetic toxicology: 1987; 188 233 239 (Pubitemid 17113005)
97. FritzJohn T. P., Williams D. G., Laker M. F. et al. Intravenous urography during lactation. Br J Radiol: 1982; 55 603 605 (Pubitemid 12035358)
98. Texier F., Roque DOrbcastel O., Etling N. Stable iodine level in human milk after pulmonary angiography. Presse Med: 1983; 19 769 (Pubitemid 13154541)
99. Saigal G., Abdenour G. E. Another case of transplacental passage of the non-ionic contrast agent ioversol. Pediatr Radiol: 2007; 37 726 727 (Pubitemid 46929954)
100. Mercieca M. D., Collier P. A., Merriman T. N. et al. Developmental toxicity study of ioxilan injection in rats and rabbits. Toxicologist: 1992; 12 105
101. Bourrinet P., Dencausse A., Cochet P. et al. Secretion in milk and transplacental transfer of two iodized oils, Lipiodol UF and Oriodol, in rabbits. Biol Neonate: 1997; 71 395 402 (Pubitemid 27254559)
102. Hua X., Zhu L. P., Li R. et al. Effects of diagnostic contrast-enhanced ultrasound on permeability of placental barrier: a primary study. Placenta: 2009; 30 780 784